Disclosure statement
The authors declare no competing financial interests.
Leukemia & Lymphoma
Volume 61, 2020 - Issue 4
Letters to the Editor
Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and network Meta-analysis
Stefano MolicaDepartment of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy; Correspondence[email protected]
http://orcid.org/0000-0003-2795-6507
http://orcid.org/0000-0003-2795-6507, & Tait D. ShanafeltDivision of Hematology, Department of Medicine, Stanford University, Stanford, CA, USAhttp://orcid.org/0000-0002-7106-5202
http://orcid.org/0000-0002-7106-5202![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})